header logo image

Biotechnology – The New York Times

August 4th, 2016 9:37 am

Latest Articles

Efforts to expand use of biotechnology to crops other than corn, soybeans, cotton and canola have been hindered by opposition from consumer and environmental groups.

By ANDREW POLLACK

Federal officials have approved a cheaper version of Johnson & Johnsons blockbuster drug Remicade, a biotech medicine for inflammatory diseases.

General Mills said on Friday that it would start labeling all products that contain genetically modified ingredients to comply with a law set to go into effect in Vermont.

The salary, bonus and stock awards given to Fords chief executive, Mark Fields, jumped 17 percent in 2015.

The senators will consider whether the government should require labeling on foods containing genetically engineered ingredients, an issue that has split the food industry.

By JENNIFER STEINHAUER and STEPHANIE STROM

A diverse biotechnology company hopes its genetically engineered mosquitoes can help stop the spread of a devastating virus. But thats just a start.

By ANDREW POLLACK

States should be free to require the labeling of genetically modified food if they want to.

By THE EDITORIAL BOARD

Bioengineers at Rice University recently found that different drops from single fingerpricks on multiple subjects varied substantially.

By DONALD G. McNEIL Jr.

With the success of growing the body parts in a lab, bioengineers are taking a step toward creating replacement organs that can be transplanted into people.

By NICHOLAS ST. FLEUR

Marc Tessier-Lavigne, who will leave Rockefeller University to lead Stanford University, has also worked as an executive in the biotech industry,

The two biotech companies initial public offerings are testing the waters after a recent sell-off in biotech.

Businesses allow parents to leverage their wealth, contacts and the hope of investors to jump-start research into the diseases that afflict their children.

By PAUL SULLIVAN

Scientists have shown that DNA molecules can be the basis for a long-term storage system potentially capable of holding all of the worlds digital information in a tiny space.

By JOHN MARKOFF

The herbicide, which contains the old herbicide 2,4-D, was to be used on crops genetically modified to be resistant to it.

The Food and Drug Administration said that the salmon would not have to be labeled as genetically engineered, consistent with its broader stance on widely eaten genetically modified foods.

Senator Orrin G. Hatch objects to language that would limit brand-name drug makers monopoly protections abroad for their cutting-edge medicines known as biologics.

By JACKIE CALMES

The case is significant because it indicates that cell therapies might not have to be customized for each patient.

By ANDREW POLLACK

An irrational phobia of genetically modified crops is causing real harm.

By MARK LYNAS

A confluence of factors, including Chinas slowing growth, falling commodity prices and trouble in the biotech sector, sent the markets lower.

Readers explain why they disagree with Dr. Ezekiel J. Emanuels proposed solutions for rising drugs costs.

Efforts to expand use of biotechnology to crops other than corn, soybeans, cotton and canola have been hindered by opposition from consumer and environmental groups.

By ANDREW POLLACK

Federal officials have approved a cheaper version of Johnson & Johnsons blockbuster drug Remicade, a biotech medicine for inflammatory diseases.

General Mills said on Friday that it would start labeling all products that contain genetically modified ingredients to comply with a law set to go into effect in Vermont.

The salary, bonus and stock awards given to Fords chief executive, Mark Fields, jumped 17 percent in 2015.

The senators will consider whether the government should require labeling on foods containing genetically engineered ingredients, an issue that has split the food industry.

By JENNIFER STEINHAUER and STEPHANIE STROM

A diverse biotechnology company hopes its genetically engineered mosquitoes can help stop the spread of a devastating virus. But thats just a start.

By ANDREW POLLACK

States should be free to require the labeling of genetically modified food if they want to.

By THE EDITORIAL BOARD

Bioengineers at Rice University recently found that different drops from single fingerpricks on multiple subjects varied substantially.

By DONALD G. McNEIL Jr.

With the success of growing the body parts in a lab, bioengineers are taking a step toward creating replacement organs that can be transplanted into people.

By NICHOLAS ST. FLEUR

Marc Tessier-Lavigne, who will leave Rockefeller University to lead Stanford University, has also worked as an executive in the biotech industry,

The two biotech companies initial public offerings are testing the waters after a recent sell-off in biotech.

Businesses allow parents to leverage their wealth, contacts and the hope of investors to jump-start research into the diseases that afflict their children.

By PAUL SULLIVAN

Scientists have shown that DNA molecules can be the basis for a long-term storage system potentially capable of holding all of the worlds digital information in a tiny space.

By JOHN MARKOFF

The herbicide, which contains the old herbicide 2,4-D, was to be used on crops genetically modified to be resistant to it.

The Food and Drug Administration said that the salmon would not have to be labeled as genetically engineered, consistent with its broader stance on widely eaten genetically modified foods.

Senator Orrin G. Hatch objects to language that would limit brand-name drug makers monopoly protections abroad for their cutting-edge medicines known as biologics.

By JACKIE CALMES

The case is significant because it indicates that cell therapies might not have to be customized for each patient.

By ANDREW POLLACK

An irrational phobia of genetically modified crops is causing real harm.

By MARK LYNAS

A confluence of factors, including Chinas slowing growth, falling commodity prices and trouble in the biotech sector, sent the markets lower.

Readers explain why they disagree with Dr. Ezekiel J. Emanuels proposed solutions for rising drugs costs.

See the original post:
Biotechnology - The New York Times

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick